Can G-quadruplex become a promising target in HBV therapy?

Teng, Ye; Zhu, Ming; Chi, Yuan; Li, Lijing; Jin, Ye

Teng, Ye; Zhu, Ming; Chi, Yuan; Li, Lijing; Jin, Ye.

Afiliação

Teng Y; School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Zhu M; School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Chi Y; Pharmaceutical Department, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Li L; School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.
Jin Y; School of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.

Front Immunol ; 13: 1091873, 2022.

Article em En | MEDLINE | ID: mdl-36591216

Assuntos

Quadruplex G; Humanos; Vírus da Hepatite B/genética; Antivirais/uso terapêutico; Antivirais/química

Palavras-chave

G-quadruplex; antiviral therapy; chronic hepatitis B virus; gene expression; interferon-stimulated gene

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quadruplex G Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google